Free Newsletter
Cervical cancer vaccine bound for clinic; Businesses warned to prepare for vax campaigns;
Vaccine Research
VGX Pharmaceuticals says that the FDA has accepted its IND for an experimental DNA vaccine for cervical cancer. VGX-3100 will go into Phase I in the third quarter. Story
Researchers at the University of Pennsylvania School of Medicine have developed a new technique that tricks the human immune system to respond against multiple strains of bird flu. Release
Sinovac Biotech has begun to recruit patients for a mid-stage study of its bird flu vaccine. Report
Genetically engineered yeast has produced an anti-tumor response in mice. Story
Monash University scientists have started clinical trials to find a successful vaccine against footrot in sheep. Report
Vaccine market
Experts are warning companies in the U.S. to start preparing now for any upcoming flu vaccination programs. Release
WellPoint, one of the largest insurers in the U.S., says that it will reimburse for the new rotavirus vaccine Rotarix. Report
Physicians in the U.K. are being warned of a shortage of vaccines for children. Story
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




